Pages that link to "Q27646554"
Jump to navigation
Jump to search
The following pages link to Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity (Q27646554):
Displaying 17 items.
- Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell Response (Q26796086) (← links)
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
- Discordant Brucella melitensis antigens yield cognate CD8+ T cells in vivo (Q33557772) (← links)
- Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. (Q33578049) (← links)
- Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed. (Q33993393) (← links)
- Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens (Q34438489) (← links)
- Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines. (Q34804723) (← links)
- Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques (Q35648017) (← links)
- Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates (Q36171855) (← links)
- Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization (Q36674446) (← links)
- Regulation of CD4 T-cell receptor diversity by vaccine adjuvants (Q37717709) (← links)
- Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1. (Q37785949) (← links)
- Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines (Q38184579) (← links)
- Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial (Q39065629) (← links)
- Transcriptional profiles reveal a stepwise developmental program of memory CD8(+) T cell differentiation. (Q41636146) (← links)
- Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity. (Q47548620) (← links)
- MHC-restricted Ag85B-specific CD8+ T cells are enhanced by recombinant BCG prime and DNA boost immunization in mice (Q92339302) (← links)